Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Part

September 10, 2026

/PRNewswire/ — Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael…

Search

RECENT PRESS RELEASES

The Odds of a September Rate Hike Just Jumped. Should You Still Buy the S&P 500?

SWI Editorial Staff2026-09-10T07:20:00-07:00September 10, 2026|

Where investors are finding income outside traditional bonds as rates rise

SWI Editorial Staff2026-09-10T07:15:01-07:00September 10, 2026|

Where investors are finding income outside traditional bonds as rates rise

SWI Editorial Staff2026-09-10T07:15:01-07:00September 10, 2026|

ContractorHUB Named a 2026 Venture Atlanta Showcase Company Among the Top Startups in the

SWI Editorial Staff2026-09-10T07:15:00-07:00September 10, 2026|

Meta is losing its most prominent AI researcher after less than a year

SWI Editorial Staff2026-09-10T07:14:57-07:00September 10, 2026|

Former bank VP, pastor pleads guilty to multi-million-dollar cattle investment fraud scheme

SWI Editorial Staff2026-09-10T07:13:48-07:00September 10, 2026|